MANE Veradermics, Incorporated
Company Analysis
Latest News
🔴 Veradermics is trading 4.8% down — no clear company-specific catalyst
Veradermics is trading 4.8% lower at $109.60, with no clear company-specific announcement explaining the October 16 move. - Available search results cite...
🔴 Veradermics is trading 4.16% down amid biotech-sector pressure
Veradermics is trading 4.16% down at $117.31 on October 13, 2026, with biotech-sector weakness potentially contributing. - No new company-specific announcement...
🔴 Veradermics is trading 4.32% down with no identified company-specific catalyst
Veradermics is trading 4.32% down at $125.25 on October 12, 2026, with no clear company-specific announcement or event explaining the decline. - Recent...
🟢 Veradermics rises 4.3% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🟢 Veradermics is trading 11.31% up
Veradermics is trading at $123.50, up 11.31%, with no clear company-specific catalyst identified for the move. - Available coverage did not identify a...
🟢 Veradermics is trading 5% up; catalyst remains unclear
Veradermics is trading 5.16% up at $116.67 on October 8, 2026, with no clear company-specific catalyst identified. - Available coverage describes recent...
🔴 Veradermics is trading 4.03% down amid biotech-sector weakness
Veradermics is trading at $114.08, down 4.03%, with biotech-sector weakness the best available explanation, though no company-specific catalyst was...
🔴 Veradermics is trading 5.9% down in pre-market — catalyst remains unclear
Veradermics is trading 5.9% down at $109.91 in pre-market on October 5, with no clear catalyst identified. - Searches found no new company announcement or...
🟢 Veradermics is trading 4% up in pre-market amid broader risk-on trading; catalyst unconfirmed
Veradermics is trading at $120.36, up +4.01%, as higher U.S. futures provide a modest broader risk-on backdrop. - The Nasdaq Composite is up 0.51%; the...
🔴 Veradermics is trading 4.5% down today amid Nasdaq and S&P 500 declines
Veradermics is trading 4.5% down at $112.83, with the decline appearing aligned with broader risk-off trading; no fresh company-specific catalyst was...
🟢 Veradermics is trading 4.5% up today with no definitive catalyst identified
Veradermics is trading 4.5% up now at $117.90, with no new company-specific announcement, earnings release, FDA action, or other definitive September 22, 2026...
🟢 Veradermics is trading 4.2% up today as oil prices and Treasury yields fall
Veradermics is trading at $111.27, up +4.23% on September 21, 2026, amid a broad risk-on session. - The S&P 500, Nasdaq Composite, and Dow Jones are higher,...
🟢 Veradermics is trading 5% up today as biotech and broader markets rally
Veradermics is trading 4.96% up at $107.33 as biotechnology and broader markets rally following the Federal Reserve decision and easing risk sentiment. - No...
🟢 Veradermics is trading 4.3% up today with no clear catalyst identified
Veradermics is trading at $103.28, up 4.3%, based on the provided live price; searches on September 14, 2026 found no clear company-specific catalyst. -...
🔴 Veradermics is trading 4.65% down today as oil prices surge and U.S.-Iran tensions escalate
Veradermics is trading 4.65% down at $99.00 as broader markets weakened amid surging oil prices and escalating U.S.-Iran geopolitical tensions. - The Dow, S&P...
🟢 Veradermics is trading 5% up today
Veradermics is trading at $103.13, up +4.69%, with no clearly reported September 8, 2026 catalyst explaining the move. - Veradermics is scheduled for investor...
🟢 Veradermics is trading 7% up in pre-market; no definitive catalyst identified
Veradermics is trading at $104.60 (+7.01%) in pre-market, while no definitive catalyst directly explaining the move has been identified. - On September 3,...
🟢 Veradermics is trading 4.6% up in pre-market
Veradermics is trading at $102.00, up +4.60% in pre-market, with no confirmed catalyst identified. - No major September 2, 2026 company-specific announcement,...
🟢 Veradermics is trading 5% up in pre-market, with no clear catalyst identified
Veradermics is trading at $103.00, up +5.18%, with no clear catalyst identified for the pre-market rebound. - No new company-specific announcement or earnings...
🔴 Veradermics falls 4.1% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...